EMA — authorised 7 November 2001
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Gleevec in European Union
EMA authorised Gleevec on 7 November 2001
Marketing authorisation
Gleevec in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Gleevec approved in European Union?
Yes. EMA authorised it on 7 November 2001.
Who is the marketing authorisation holder for Gleevec in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.